More about Hexarelin
Hexarelin is a chemically synthesized growth hormone secretagogue receptor ligand supplied for controlled in-vitro laboratory research. It is commonly used as a reference compound in experimental models examining receptor binding, ligand selectivity, structure-activity relationships, and endocrine signaling mechanisms.
NordSci supplies Hexarelin as a lyophilized research material manufactured to defined specifications. Batch-specific analytical testing is used to assess identity and purity for laboratory procurement and quality-control purposes.
Hexarelin Research Peptide Specifications:
| Unit Size |
5 mg/vial |
| Unit Quantity |
1 vial |
| Purity (HPLC) |
>99% |
| Sequence |
His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2 |
| Molecular Formula |
C47H58N12O6 |
| Molecular Weight |
Approximately 887.0 g/mol |
| CAS Number |
140703-51-1 |
| Appearance |
Lyophilized white to off-white powder |
| Source |
Chemical synthesis |
| Storage Conditions |
Store sealed lyophilized material at or below -20°C in a dry, dark environment. Follow the Certificate of Analysis and applicable institutional laboratory procedures. |
| Research Use Only |
For in-vitro laboratory research only. Not for human or animal consumption or any clinical, veterinary, diagnostic, therapeutic, food, cosmetic, or supplement application. |
What is Hexarelin? Research Background and Mechanism
Hexarelin, also known as examorelin, is a synthetic six-amino-acid peptide classified as a growth hormone secretagogue receptor ligand. Its molecular structure and receptor-binding characteristics have made it a subject of controlled laboratory investigation involving peptide chemistry, ligand-receptor interactions, and endocrine pathway analysis.[1,2]
Experimental work involving Hexarelin may examine receptor affinity, signaling selectivity, assay response, molecular stability, and relationships between receptor activation and measurable laboratory endpoints. These investigations require appropriate controls, validated analytical methods, and clearly defined experimental conditions.
Key research domains include:
- Growth hormone secretagogue receptor characterization
- Ligand-binding and receptor-selectivity assays
- Endocrine signaling pathway analysis
- Peptide structure-activity relationship studies
- Comparative secretagogue research models
- Analytical identity, purity, and stability testing
Hexarelin is supplied solely as a laboratory research material. References to biological pathways describe areas of scientific investigation and do not indicate an approved or intended use in humans or animals.
Hexarelin Research Focus Areas
1. Growth Hormone Secretion and Endocrine Axis Modulation
Hexarelin has been examined in laboratory research involving growth hormone secretagogue receptor activity and associated endocrine signaling pathways.[1,2] These studies may use controlled assays to characterize receptor engagement, signaling responses, feedback relationships, and interactions among experimental variables.
Laboratories may compare Hexarelin with other reference compounds to investigate differences in molecular structure, receptor affinity, assay behavior, and pathway selectivity. Findings remain specific to the experimental model, methodology, and conditions under which they were generated.
2. Cardiovascular and Myocardial Protection Models
Published experimental literature has evaluated Hexarelin-related receptor activity in models containing cardiac or vascular tissues.[3–5] These investigations are framed as mechanistic studies of receptor distribution, cellular signaling, molecular interactions, and assay-specific biomarkers.
Hexarelin is not supplied for cardiovascular treatment, myocardial protection, disease management, or any clinical application. References to these models identify areas of laboratory investigation only and do not establish safety, effectiveness, or therapeutic utility.
3. Bone, Muscle, and Body-Composition Research
Certain laboratory studies have included musculoskeletal tissues or related cellular models when examining growth hormone secretagogue signaling.[2,4] These studies may assess receptor expression, pathway activation, molecular markers, and controlled experimental responses.
Such research does not establish that Hexarelin changes muscle mass, bone density, strength, body composition, or physical performance. The material is not intended for exercise, physique, recovery, or body-composition applications.
4. Metabolic and Weight-Related Endpoints
Hexarelin has appeared in experimental literature involving metabolic signaling and laboratory biomarkers.[3–5] These studies may investigate interactions among receptor activity, endocrine pathways, and predefined analytical endpoints under controlled conditions.
Hexarelin is not a weight-management product and is not supplied for appetite control, fat reduction, metabolic enhancement, obesity treatment, or changes in body composition. Laboratory observations should be interpreted only within the limitations of the applicable research model.
Important Research Notice: NordSci research materials undergo independent third-party laboratory testing to assess identity and purity. Batch-specific Certificate of Analysis documentation is available to support laboratory quality-control and procurement requirements.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR IN-VITRO LABORATORY RESEARCH. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR CLINICAL, VETERINARY, DIAGNOSTIC, THERAPEUTIC, FOOD, COSMETIC, OR SUPPLEMENT USE.
Hexarelin Certificate of Analysis (COA) – Lab Testing
NordSci provides batch-specific analytical documentation for Hexarelin. Available documentation may include HPLC purity analysis and mass spectrometry identity confirmation.
Download Hexarelin COA Lab Test Results
Where to Buy Hexarelin for Research Purposes
Laboratories procuring Hexarelin should evaluate product identity, stated purity, batch traceability, storage requirements, labeling, and the availability of analytical documentation. Procurement decisions should be made according to institutional policies and applicable laws governing laboratory research materials.
How to Source Hexarelin for Laboratory Research
Researchers should confirm that the supplier provides clearly defined product specifications, a research-use-only designation, batch-specific analytical documentation, and appropriate storage information. Laboratories may also conduct independent identity or purity testing when required by institutional policy or experimental design.
Hexarelin Research Peptide Pricing Considerations
Research-material pricing may vary according to unit quantity, purity specification, analytical testing, batch documentation, and storage requirements. Procurement teams should assess these factors together rather than relying exclusively on unit price.
Research Institution Procurement and Compliance
Principal investigators, laboratory managers, and purchasing teams are responsible for ensuring that acquisition and possession comply with institutional purchasing policies, chemical inventory procedures, access controls, safety requirements, and applicable regulations.
No dosing, administration, application, or bodily-use instructions are provided. Hexarelin must remain within authorized laboratory channels and may not be introduced into humans or animals.
IMPORTANT: Hexarelin is sold exclusively for in-vitro laboratory research. It is not approved for human or veterinary use or for any clinical, diagnostic, or therapeutic application. Researchers and purchasing institutions are responsible for compliance with all applicable requirements in their jurisdiction.
Scientific References
-
Bowers CY, et al. Hexarelin, a peptidyl growth hormone secretagogue, and the regulation of GH secretion in humans. J Clin Endocrinol Metab. 1997.
-
Ghigo E, et al. Growth hormone-releasing peptides. Eur J Endocrinol. 2000.
-
Poehlman ET, et al. Effects of GH secretagogues on body composition and endocrine function: insights from preclinical and clinical models. Horm Res. 2005.
-
Bisi G, et al. Cardiovascular effects of Hexarelin in experimental heart failure. Endocrine. 2003.
-
Growth hormone secretagogues and the cardiovascular system. Ann Endocrinol (Paris). 2003.
ALL PRODUCT INFORMATION PROVIDED ON THIS WEBSITE IS FOR INFORMATIONAL AND LABORATORY RESEARCH PURPOSES ONLY.
The products offered on this website are furnished exclusively for in-vitro laboratory studies performed outside a living organism. They are not medicines, drugs, dietary supplements, foods, or cosmetics and have not been approved by the FDA to diagnose, treat, cure, or prevent any disease or condition. Introduction into humans or animals is strictly prohibited.
Related Research Articles